Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate
2007-05-15
2007-05-15
Canella, Karen A. (Department: 1643)
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
C424S620000, C424S621000, C424S624000, C514S002600, C514S021800
Reexamination Certificate
active
09744605
ABSTRACT:
The invention concerns the use of novel agents including cell death, and in particular, an agent for overexpression of the PML protein on nuclear bodies, combined with interferons, to induce the death of undesirable cells and simulate an immune reaction.
REFERENCES:
patent: 6733792 (2004-05-01), Lu
patent: 2002/0001841 (2002-01-01), Kaltoft et al.
patent: PCT/CN98/00118 (1999-11-01), None
patent: WO 02/18572 (2002-03-01), None
Zhu, et al., Proc Natl Acad Sci U S A Apr. 15, 1997;94(8):3978-83.
U.S. Appl. No. 60/091,684.
Gianni et al (Blood, Jun. 1, 1998, vol. 91, pp. 4300-4310).
Bazarbachi et al (Blood, Jan. 1, 1999, vol. 93, pp. 278-283).
Chelbi-Alix et al (Leukemia, 1995, vol. 9, pp. 2027-2033).
Zhu et al (PNAS, 1997, vol. 94, pp. 3978-3983).
He et al (Anticancer Research, 1997, vol. 17, No. 5C, p. 3927, abstract #6).
Muller et al (EMBO, Jan. 2, 1998, vol. 17, pp. 61-70).
Chelbi-Alix et al (NATO ASI Series H: Cell Biology (1996, vol. 99 (Tumor Biology), pp. 17-27).
Chen et al (blood, vol. 88, pp. 1052-1061).
Albert et al (Nature, Mar. 5, 1998, vol. 392, pp. 86-89).
Lutz et al (Trends in Immunology, 2002, vol. 23, pp. 445-449).
Sauter et al (Journal of Experimental Medicine, 2000, vol. 191, pp. 423-433).
Perry et al (Biotechniques, 1997, vol. 22, pp. 1102-1106).
Takahashi et al, Oncogene, 2004, vol. 23, pp. 2819-2824.
Wadia and Dowdy, Advanced Drug Delivery Reviews, 2005, vol. 57, pp. 579-596.
Johnson and Tracey, ‘Peptide and Protein Drug Delivery’, In: Encyclopedia of Controlled Drug Delivery, vol. 2, 1999, pp. 816-833.
Lallemand-Breitenbach et al, Journal of Experimental Medicine, 2001 vol. 193, pp. 1361-1371.
Xiang, BAX-induced cell death may not require interleukin 1—converting enzyme-like proteases, Proc. Natl. Acad. Sci. USA, vol. 93, pp. 14559-14563, Dec. 1996, Cell Biology.
Quignon, PML induces a novel caspase-independent death process, Nature Genetics, vol. 20, pp. 259-265, Nov. 1998.
Vercammen, Inhibition of Caspases Increases the Sensitivity of L929 Cells to Necrosis Mediated by Tumor Necrosis Factor, J. Exp. Med., The Rockefeller University Press, vol. 187, No. 9, pp. 1477-1485, May 4, 1998.
Griffith, CD95-Induced Apoptosis of Lymphocytes in an Immune Privileged Site Induces Immunological Tolerance, Immunity, vol. 5, pp. 7-16, Jul. 1996.
Voll, Immunosuppressive effect of apoptotic cells, Nature, vol. 390, pp. 360-361, Nov. 27, 1997.
Gao, Antiinflammatory Effects of CD 95 Ligand (FasL)-induced Apoptosis, J. Exp. Med., The Rockefeller University Press, vol. 188, No. 5, pp. 887-896, Sep. 7, 1998.
Melcher, Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression, Nature Medicine, vol. 4, No. 5, pp. 581-587, May 1998.
Byrd, Old and New Therapies in Chronic Lymphocytic Leukemia: Now Is the Time for a Reassessment of Therapeutic Goals, Seminars in Oncology, vol. 24 (1), pp. 65-74, Feb. 1998.
Soignet, Clinical and laboratory studies in leukemia of an organic arsenical melarsoprol, Proc. of ASCO, vol. 16, pp. 4A, 1997.
Konig, Comparative Activity of Melarsoprol and Arsenic Trioxide in Chronic B-Cell Leukemia Lines, Blood, vol. 90 (2), pp. 562-570, Jul. 15, 1997.
Slee, Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32, Biochem. J., vol. 315, pp. 21-24, 1996.
Ameisen Jean-Claude
De Bels Frédéric
De The Hugues
Koken Marcel
Quignon Frédérique
Browdy & Neimark PLLC
Canella Karen A.
Centre National de la Recherche Scientifique "CNRS"
Institut de la Sante et de la Recherde Medicale (INSERM)
LandOfFree
Use of novel agents inducing cell death in synergy with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of novel agents inducing cell death in synergy with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of novel agents inducing cell death in synergy with... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3814892